在脏疾病中的多不和脂肪酸:在治愈和损伤之间的细线上航行
Mehrdad Aghasizadeh1, Ahmad Reza Bahrami2, Maryam M Matin3
1Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
概括
多不和脂肪酸 (PUFA) 通过产生有害或有益的代谢物,影响脏健康. 针对这些脂质媒介提供了针对炎症性脏疾病的新疗法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 脂质代谢 脂质代谢是什么
- 炎症生物学 炎症生物学
背景情况:
- 多不和脂肪酸 (PUFA) 对于通过COX,LOX和CYP途径的代谢物调节炎至关重要.
- 前列腺素,白血球蛋白和20-HETE会恶化损伤,而环氧氨酸酸 (EETs),脂素和专门的亲溶解媒介 (SPMs) 会促进损伤的修复.
- PUFA代谢的失衡与各种脏疾病有关,包括脏综合征和血球膜炎.
研究的目的:
- 审查PUFA衍生的脂质媒介在脏炎症和修复中的作用.
- 探索针对这些中介体治疗脏疾病的治疗策略.
- 讨论该领域的挑战和未来方向.
主要方法:
- 机械学见解与实验和临床数据的整合.
- 关于脏疾病中PUFA代谢的文献综述.
- 分析治疗方法及其局限性.
主要成果:
- PUFA代谢产物有双重作用:一些会加剧损伤,而另一些会解决炎症并促进愈合.
- 脂质介质调节PPAR和TGF-β信号传递等关键通路.
- 治疗策略包括饮食中的PUFA补充剂,SPM类似物,酶抑制剂和纳米载体系统.
结论:
- 向PUFA衍生的脂质介质是对炎症和免疫介导脏疾病的有前途的辅助疗法.
- 脂质组分析可以个性化治疗策略.
- 需要进一步的研究来克服短半衰期和非目标效应等局限性.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
80
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
80
Nephrons
3.5K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.5K
Chronic Kidney Disease I: Introduction
73
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
73
Nephrotic Syndrome I : Introduction
29
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
29
Chronic Kidney Disease II: Clinical Manifestations
96
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
96
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57


